Leadership

Jane E. Freedman, MD

Dr. Freedman is the Chair of the Department of Medicine at Vanderbilt University Medical Center. She is the Gladys Parkinson Stahlman Professor of Cardiovascular Research and Physician-in-Chief of Vanderbilt University Adult Hospital.

Prior to assuming the interim chair role in December 2023, she was the director of the Division of Cardiovascular Medicine and Physician-in-Chief of the Vanderbilt Heart and Vascular Institute. She is the current Editor-in-Chief for Circulation Research, and has also served as the Chair of the National American Heart Association Peer Review Committee.

Dr. Freedman has extensive mentoring experience and has been the PI of three T32 Training Grants. She currently oversees two research programs. The first is a basic science laboratory that examines the role of immunity, infection, and inflammation on atherothrombotic disease. The second facility uses high-throughput, nano-chip, and RNA-seq technologies to study gene expression and provide large scale transcriptomic and proteomic translational data for a wide range of clinical and translational projects.

Dr. Freedman has received young investigator awards from both the AHA and the ACC, was been elected to the A.S.C.I. and the A.U.C. She is a past Associate and Senior Editor for Circulation.

Kahraman Tanriverdi, PhD

Dr. Tanriverdi is a Research Professor in the Division of Cardiovascular Medicine, Department of Medicine, at Vanderbilt University Medical Center.

He is the director of High-Throughput Biomarker Core, collaborating throughout the world using high-throughput and nano-chip technologies and RNAseq to study gene expression (mRNA, miRNA, exRNA) and provide translational data (proteomics, biomarker, transcriptomics and genomic measurements) for a wide range of projects. This laboratory has generated data for dozens of clinical studies both large and small.

Dr. Tanriverdi developed a unique miRNA expression profiling platform with the integration of miRNA primer library and Integrated Fluidic Circuit technology. Combination of these two unique technologies has given the lab the high throughput analysis with precision of gold standard RT-qPCR as well as OLink proteomic measurements.